Tuesday, February 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Goldman Sachs Downgrades American Homes 4 Rent Amid Market Oversupply Concerns

Felix Baarz by Felix Baarz
September 18, 2025
in Analysis, Real Estate & REITs, S&P 500
0
American Homes 4 Rent Stock
0
SHARES
141
VIEWS
Share on FacebookShare on Twitter

Goldman Sachs has revised its position on single-family rental operator American Homes 4 Rent (AMH), shifting its rating from “Buy” to “Neutral.” Concurrently, the investment bank has reduced its price target for the company’s shares from $43 to $37. This decision stems from mounting apprehensions regarding a surplus of rental properties entering the market and the subsequent pressure this is placing on rental rate growth.

Oversupply Dynamics Challenge Sector Outlook

According to analysis by Goldman Sachs strategist Julien Blouin, the current environment is becoming increasingly challenging for residential real estate equities. A significant influx of single-family homes is appearing on the rental market within American Homes 4 Rent’s key operational areas. The report details a trend where home sellers are becoming “involuntary landlords,” and homebuilders are opting to convert properties originally intended for sale into rental units.

This emerging “shadow supply” of rental homes is now substantially outpacing tenant demand in these critical regions. The resulting imbalance is exerting downward pressure on achievable rental rates, directly impacting the revenue potential for companies like American Homes 4 Rent.

Financial Forecasts Adjusted Below Consensus

In light of these market conditions, Goldman Sachs has downwardly revised its core Funds From Operations (FFO) projections for AMH. The updated estimates now sit 0.7% below the market consensus for 2025 and a full 2.0% below for 2026.

The specific adjustments are:
* 2025 Forecast: Reduced by 0.1%
* 2026 Forecast: Reduced by 1.9%

Should investors sell immediately? Or is it worth buying American Homes 4 Rent?

The analyst team believes current market expectations are underestimating the seasonal slowdown in new lease rates anticipated for the latter half of 2025. Furthermore, they contend that projections may be overestimating the acceleration in lease renewal rates expected in the first half of 2026.

Mixed Sentiment Persists Among Analysts

The downgrade from Goldman Sachs presents a contrasting view to other firms covering the stock, highlighting a divided analytical landscape.

  • Evercore ISI maintains an “Outperform” rating, though it slightly trimmed its price target from $41 to $40.
  • Mizuho continues to recommend “Outperform” but lowered its target from $38 to $36, citing concerns over property taxes.
  • Citizens JMP reaffirmed its “Market Outperform” rating and a $41 price objective following the company’s robust second-quarter performance.

AMH demonstrated significant operational strength in Q2, reporting earnings per share (EPS) of $0.28, which handily exceeded the $0.17 forecast. Revenue for the quarter reached $457.5 million.

The critical question for investors is whether American Homes 4 Rent can overcome the negative momentum identified by Goldman Sachs. The coming weeks will be pivotal in determining if these concerns are warranted or if the company’s underlying operational performance will prevail.

Ad

American Homes 4 Rent Stock: Buy or Sell?! New American Homes 4 Rent Analysis from February 3 delivers the answer:

The latest American Homes 4 Rent figures speak for themselves: Urgent action needed for American Homes 4 Rent investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 3.

American Homes 4 Rent: Buy or sell? Read more here...

Tags: American Homes 4 Rent
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Acadia Stock
Analysis

Setback in Europe Clouds Growth Outlook for Acadia

February 3, 2026
QuantumScape Stock
Analysis

QuantumScape’s Pivotal Year: Scaling Up for Commercial Validation

February 3, 2026
CNO Stock
Analysis

CNO Financial Earnings Report: A Strategic Pivot Under the Microscope

February 3, 2026
Next Post
Regency Centers Stock

Regency Centers Gains Analyst Favor Through Strategic Development Push

Agree Realty Stock

A Defensive Powerhouse: Agree Realty's Strategic Edge in Net-Lease Investing

Alpine Immune Sciences Stock

Vertex Pharmaceuticals Secures Future Pipeline with $4.9 Billion Alpine Immune Sciences Acquisition

Recommended

Biotechnology Trading online

Decline in Short Interest for Adobe NYSE ADBE Signals Bullish Sentiment

2 years ago
Cisco Stock

Cisco Stock Surges as Artificial Intelligence Drives Infrastructure Demand

3 months ago
Adaptive Biotechnologies Stock

Strategic Shift: Adaptive Biotechnologies Severs Major Pharma Alliance

6 months ago
Puma Stock

Puma Shares Face Critical Test Amid Mounting Challenges

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Q2 Holdings to Report Full-Year 2025 Financial Results

Merck KGaA’s Strategic Acquisition of SpringWorks Therapeutics Gains Momentum

Commerce Bancshares Surpasses Market Forecasts in Year-End Report

Strategic Moves at Genworth Financial Ahead of Earnings

BancFirst Strengthens Regional Footprint with Acquisition Finalization

iShares MAFE ETF Reaches Fresh 52-Week Peak

Trending

Acadia Stock
Analysis

Setback in Europe Clouds Growth Outlook for Acadia

by Robert Sasse
February 3, 2026
0

Acadia Pharmaceuticals has encountered a significant obstacle for its European expansion strategy. Market uncertainty followed the announcement...

QuantumScape Stock

QuantumScape’s Pivotal Year: Scaling Up for Commercial Validation

February 3, 2026
CNO Stock

CNO Financial Earnings Report: A Strategic Pivot Under the Microscope

February 3, 2026
Q2 Holdings Stock

Q2 Holdings to Report Full-Year 2025 Financial Results

February 3, 2026
SpringWorks Therapeutics Stock

Merck KGaA’s Strategic Acquisition of SpringWorks Therapeutics Gains Momentum

February 3, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Setback in Europe Clouds Growth Outlook for Acadia
  • QuantumScape’s Pivotal Year: Scaling Up for Commercial Validation
  • CNO Financial Earnings Report: A Strategic Pivot Under the Microscope

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com